Pharma Pulse: Precision Cancer Care

Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines.

• First, Novartis is scaling up treatment. The pharma giant has announced plans to build its fourth US-based radioligand therapy facility. This move is a massive bet on precision oncology. The facility is expected to be completed by 2029, and is anticipated to bolster the Big Pharma company’s specialized supply chain and manufacturing services across its vast RLT production facility network.
• But the industry’s progress faces a major hurdle on the front lines: labor. In New York City, nearly 15,000 nurses have gone on strike at major medical centers. The walkout underscores a breaking point in healthcare, with nurses citing staffing ratios and pay. It’s a stark reminder that even the best medicines can’t reach patients if the delivery system is fractured.

That’s it for this episode of Pharma Pulse. For more insights on trends transforming pharmaceutical access and care delivery, visit pharmaceuticalcommerce.com.

Thanks for listening—until next time, stay well and stay informed.

You can catch Pharma Pulse directly on Audioboom, Spotify, or iHeart.